Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Sihuan Kebao Pharmaceutical is a major pharmaceutical manufacturing entity and a key subsidiary of Sihuan Pharmaceutical Holdings Group, located in Ma'anshan, Anhui Province. The company focuses on the development and large-scale production of various therapeutic agents, particularly in the fields of cardiovascular, cerebrovascular, and digestive health. Its manufacturing infrastructure includes multiple GMP-certified lines for small-volume injections and solid oral dosage forms like tablets and capsules. Anhui Sihuan Kebao plays a vital role in the commercialization of the parent group's portfolio, producing leading products such as Kelinao and Oulaining. The company represents a significant component of Sihuan's integrated supply chain, supporting its position as a top-tier pharmaceutical player in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Sihuan Kebao Pharmaceutical.